Bicyclic amines as CDK2 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11851426
SERIAL NO

17067203

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application provides bicyclic amines that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INCYTE CORPORATION1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Zhenwu Wilmington, US 29 1290
Qian, Ding-Quan Newark, US 83 2121
Winterton, Sarah Wilmington, US 4 36
Wu, Liangxing Wilmington, US 154 4465
Yao, Wenqing Chadds Ford, US 305 8074
Ye, Yingda Wilmington, US 18 409

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 26, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 26, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 26, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00